Furthermore, 45 women were diagnosed with a HER2 + BC, 29 had a triple-negative breast cancer (TNBC), and the remaining presented luminal-like tumors (one Luminal A and seven Luminal B). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.